newsfilter
← Latest News
PR Newswire·

Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."

FORT COLLINS, Colo., Aug. 31, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ:CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced plans to change its corpora